Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer

被引:96
|
作者
Kim, Hye Jeong [1 ]
Kim, Na Kyung [1 ]
Choi, Ji Hun [1 ]
Sohn, Seo Young [1 ]
Kim, Se Won [1 ]
Jin, Sang-Man [1 ]
Jang, Hye Won [1 ]
Suh, Sunghwan [1 ]
Min, Yong-Ki [1 ]
Chung, Jae Hoon [1 ]
Kim, Sun Wook [1 ]
机构
[1] Sungkyunkwan Univ, Div Endocrinol & Metab, Dept Med, Samsung Med Ctr,Sch Med, 50 Irwon Dong, Seoul 135710, South Korea
关键词
ADIPONECTIN CONCENTRATIONS; RISK; OBESITY; CARCINOMA; LEPTIN; WEIGHT; MEN;
D O I
10.1111/j.1365-2265.2012.04506.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Epidemiological studies have demonstrated that excess weight increases the risk of thyroid cancer. However, the associations between excess weight and prognostic factors for thyroid cancer are uncertain. We evaluated the relationships between body mass index (BMI) and clinico-pathological features and outcomes of papillary thyroid cancer (PTC). Patients and Methods Retrospective analysis of 2057 patients with PTC was performed. Patients were grouped according to BMI (underweight, normal weight, overweight and obesity)-based World Health Organization standardized categories. Logistic regression models were used to assess the relationships between BMI and clinico-pathological features of PTC. A Cox proportional hazards model was used to examine the association between BMI and disease recurrence. Results A 5-kg/m2 increase in BMI was associated with PTC tumours larger than 1 cm [odds ratio (OR) 1.31, P < 0.001], with microscopic extrathyroidal invasion (OR 1.23, P = 0.006), and with advanced tumour-node-metastasis (TNM) stage (OR, 1.30, P = 0.003), which is independent of confounding variables such as gender, age, serum TSH, total cholesterol and fasting glucose level. The multivariate-adjusted OR [95% confidence intervals (CI)] in the overweight (25.029.9 kg/m2) and obese (BMI = 30) groups for tumours larger than 1 cm were 1.41 (1.101.81) and 2.17 (1.233.82), respectively, compared to the normal weight group (BMI 18.524.9). The multivariate-adjusted OR (95% CI) for microscopic extrathyroidal extension in the obesity group was 1.88 (1.063.32), and the OR for advanced TNM stage in the overweight group was 1.35 (1.021.79) compared to the normal weight group. During follow-up (median, 84 month; range, 1185), 43 patients (2.1%) experienced recurrence. There were no significant differences in recurrence of PTCs among BMI groups. Conclusions Higher BMI was strongly associated with larger tumour size, extrathyroidal invasion and advanced TNM stage of PTCs. However, there was no difference in recurrence rate among BMI groups. This study suggests that excess weight is associated with aggressive features of PTCs. Further studies with long-term follow-up are needed to confirm this finding.
引用
收藏
页码:134 / 140
页数:7
相关论文
共 50 条
  • [41] Associations between body mass and papillary thyroid cancer stage and tumor size: a population-based study
    Peter Dieringer
    Evan M. Klass
    Brenna Caine
    Julie Smith-Gagen
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 93 - 98
  • [42] Associations between body mass and papillary thyroid cancer stage and tumor size: a population-based study
    Dieringer, Peter
    Klass, Evan M.
    Caine, Brenna
    Smith-Gagen, Julie
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (01) : 93 - 98
  • [43] CLINICO-PATHOLOGICAL STUDIES OF CANCER DISTRIBUTION IN AFRICA
    BURKITT, DP
    HUTT, MSR
    SLAVIN, G
    BRITISH JOURNAL OF CANCER, 1968, 22 (01) : 1 - +
  • [44] Clinico-pathological profile of lung cancer in Uttarakhand
    Rawat, Jagdish
    Sindhwani, Girish
    Gaur, Dushyant
    Dua, Ruchi
    Saini, Sunil
    LUNG INDIA, 2009, 26 (03) : 74 - 76
  • [45] Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer
    Isnaldi, Edoardo
    Garuti, Anna
    Cirmena, Gabriella
    Scabini, Stefano
    Rimini, Edoardo
    Ferrando, Lorenzo
    Lia, Michela
    Murialdo, Roberto
    Tixi, Lucia
    Carminati, Enrico
    Panaro, Andrea
    Gallo, Maurizio
    Grillo, Federica
    Mastracci, Luca
    Repetto, Lazzaro
    Fiocca, Roberto
    Romairone, Emanuele
    Zoppoli, Gabriele
    Ballestrero, Alberto
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (1)
  • [46] Male breast cancer: Clinico-pathological characteristics from the national cancer database (NCDB)
    Elimimian, Elizabeth Blessing
    Elson, Leah
    Liang, Hong
    Nahleh, Zeina
    CANCER RESEARCH, 2020, 80 (04)
  • [47] Neurofascin-155 autoimmunity: clinico-pathological associations and outcomes
    Shelly, Shahar
    Paul, Pritikanta
    Klein, Christopher
    Fryer, James
    Basal, Eati
    Berini, Sarah
    Mauermann, Michelle
    McKeon, Andrew
    Pittock, Sean
    Mills, John
    Dubey, Divyanshu
    NEUROLOGY, 2021, 96 (15)
  • [48] Clinico-pathological characteristics of younger, middle aged, and older patients with colon cancer
    Salem, M.
    Kaufman, M.
    Stanski, N.
    Dyson, G.
    Krasnick, B.
    Choi, M.
    Hawk, N.
    El-Rayes, B.
    Philip, P.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S526 - S526
  • [49] Thyroid cancer in Iceland in the period 1955-2004. A clinico-pathological and epidemiological study
    Jonasson, Jon Gunnlaugur
    Hrafnkelsson, Jon
    Olafsdottir, Elinborg
    LAEKNABLADID, 2011, 97 (02): : 83 - 89
  • [50] Malignant breast papillary neoplasm: a clinico-pathological study of 27 cases
    Bchir, A.
    Chaieb, S.
    Nfikha, Z.
    Fejji, Y.
    Tlili, T.
    Abdessayed, N.
    Zahmoul, T.
    Hamchi, H.
    Sriha, B.
    Mokni, M.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S6 - S6